Buys
Open market- Shares
- Avg price
- Total value
Khurram Jamil - Chief Medical Officer at GALECTIN THERAPEUTICS INC
Issuer-level insider activity
- Role
- Chief Medical Officer
- Issuer ticker
- GALT on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Khurram Jamil in GALECTIN THERAPEUTICS INC
Sells
Open market- Shares
- -285,096
- Avg price
- $5.04
- Total value
- -$1,435,731
Net
Past year- Shares
- -285,096
- Share %
- -100%
- Total value
- -$1,435,731
Reported holdings for Khurram Jamil in GALECTIN THERAPEUTICS INC
Form 4 holding
Chief Medical Officer
GALECTIN THERAPEUTICS INC
- Security class
- Restricted Stock Unit
- Shares / value
- 100,000
- Estimated value
- $69,600
- Report date
- 16 Jan 2026
- Price
- $1.16
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Medical Officer
GALECTIN THERAPEUTICS INC
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 14 Jul 2026
- Price
- $5.13
- Ownership
- Direct
Form 4 holding
Chief Medical Officer
GALECTIN THERAPEUTICS INC
- Security class
- Stock option (right to buy)
- Shares / value
- 48,750
- Estimated value
- Report date
- 14 Jul 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Khurram Jamil in GALECTIN THERAPEUTICS INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.